Site search
Correspondence address
310 Mira Street, Stavropol, Russia, 355017
Tel
+7 865 2352511, +7 865 2353229.
E-mail
medvestnik@stgmu.ru
The journal is included into The list of leading scientific periodicals.
The journal is included into VINITI database and is registered in Electronic scientific library.
The journal is indexed by SCOPUS, Ulrich's International Periodicals Directory.
[Oncology]
Irina Goroshinskaja; Alexey Shevchenko; Elena Filatova; Lyudmila Nemashkalova;
The purpose of the study was to analyze the levels of C-reactive protein (CRP), haptoglobin (HG) and ceruloplasmin (CP) in blood of patients with non-muscle invasive bladder cancer (BC) before treatment and after adjuvant intravesical gemcitabine chemotherapy (CT) accompanied by the simultaneous action of a local electromagnetic field (MF). The content of acute phase proteins and ceruloplasmin oxidase activity were analyzed in the treatment of 60 BC patients with the use of CT MF (main group) and without it (control group) in comparison with indicators of patients without cancer pathology. Before treatment, patients with BC were characterized by elevated levels of acute phase proteins: CRP by 5.7 times and HG by 60%. After completion of CT normalization of CRP, decrease in HG content, increased CP content and its oxidase activity were revealed. Patients in the control group were characterized by a decrease in the level of CRP, which was significantly less pronounced than in the main group. The data indicate a decrease in the inflammatory component, increase of the blood antioxidant potential under the influence of scanning electromagnetic effects and are consistent with the clinical efficacy of this method for treating bladder cancer, as well as confirm the information content of the definition of CRP as an additional test of oncourology patients state.
References:
1. Vashhenko V. I., Vashhenko T. N. Psihofarmakologija i biologicheskaja narkologija. – Psychopharm. boil. narcology. 2006;6(3):1254-1269.
2. Goroshinskaja I. A., Vashhenko L. N., Mashurova S. A., Shalashnaja E. V. Rossijskij medicinskij zhurnal. – Russian Med. J. 2014;4:18-22.
3. Goroshinskaja I. A., Nerodo G. A., Surikova E. I., Kachesova P. S., Shalashnaja E. V., Nerodo E. A., Nemashkalova L. A., Leonova A. V. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. – Int. J. Appl. Basic Res. 2014;4:53-56.
4. Kamyshnikov V. S. Metody klinicheskih laboratornyh issledovanij. 6-e izd. M.: «MEDpress-inform»; 2013. 736 p.
5. Kit O. I., Durickij M. N., Sheljakina T. V., Maksimova N. A., Legostaev V. M. Sovremennye problemy nauki i obrazovanija. – Modern problems of science and education. 2015;4. URL: http://www.science-education.ru/ru/ article/view?id=20467.
6. Men’shhikova E. B., Lankin V. Z., Zenkov N. K., Bondar’ I. A., Krugovyh N. F., Trufakin V. A. Okislitel’nyj stress. Prooksidanty i antioksidanty. M.; 2006. 556 p.
7. Nerodo G. A., Goroshinskaja I. A., Ivanova V. A., Surikova E. I., Kachesova P. A., Shalashnaja E. V., Nerodo E. A., Nemashkalova L. A., Leonova A. V. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. – Int. J. Appl. Basic Res. 2014;8(3):62-66.
8. Surikova E. I., Goroshinskaja I. A., Maksimova N. A., Kachesova P. S., Sergeeva M. M. Rossijskij medicinskij zhurnal. – Russian Med. J. 2015;2:29-33.
9. Titov V. N. Klinicheskaya laboratornaya diagnostika. – Clinical laboratory diagnostics. 2010;8:3-16.
10. Shvarcburd P. M. Voprosy onkologii. – Questions of Oncology. 2006;52(2):137-144.
11. Shihljarova A. I., Tarnopol’skaja O. V., Shevchenko A. N., Filatova E. V., Kurkina T. A., Seleznev S. G., Shvyrev D. A., Homutenko I. A., Tarakanov M. V. Mezhdunarodnyj zhurnal prikladnyh i fundamental’nyh issledovanij. – Int. J. Appl. Basic Res. 2014;10:32-36.
12. Allin K. H., Nordestgaard B. G. Crit. Rev. Clin. Lab. Sci. 2011;48(4):155-170. doi: 10.3109/10408363.20 11.599831
13. Aref H., Refaat S. Egyptian Journal of Chest Diseases and Tuberculosis. 2014;63:717-722.
14. Arner E., Forrest A. R. R., Ehrlund A., Mejhert N., Itoh M., Kawaji H., Lassmann T., Laurencikiene Ju., Rydén M., Arner P. Published; 2014. doi: 10.1371/journal. pone.0080274
15. Dai J., Tang K., Xiao W., Yu G., Zeng J., Li W., Zhang Y. Q., Xu H., Chen Z. Q., Ye Z. Q. Asian Pac. J. Cancer Prev. 2014;15(8):3369-3375.
16. Pirinççi N., Geçit I., Guneş M., Kemik A. S., Yüksel M. B., Kaba M., Ceylan K., Aslan M. Asian Pacific J. Cancer Prev. 2012;13(12):6063-6066. doi: 10.7314/APJCP. 2012.13.12.6063
17. Saito K., Kihara K. Int. J. Urol. 2013;20(2):161-171. doi: 10.1111/j.1442-2042.2012.03121.x. Epub 2012 Aug 16.
18. Wang C. S., Sun C. F. Chang Gung Med. J. 2009;32:471- 482.
19. Zainal I. G., AL-Dori M., Abdul A.-N. M. Eng. & Tech. Journal. 2009;27(4):751-758.
20. Zhou L., Cai X., Liu Q., Jian Z. Y., Li H., Wanga K. J. Sci Rep. 2015;5:12733. Published online 2015 Aug 3. doi: 10.1038/srep12733
Keywords: non-muscle invasive bladder cancer, C-reactive protein, haptoglobin, ceruloplasmin, scanning magnetic field